Official websites use .gov
Secure .gov websites use HTTPS
Neuromuscular blocking agents: reducing associated wrong-drug errors
Neuromuscular blocking agents: reducing associated wrong-drug errors
- Collection:
- Health Policy and Services Research
- Series Title(s):
- Pennsylvania patient safety advisory
- Contributor(s):
- Pennsylvania. Patient Safety Authority.
ECRI (Organization)
Institute for Safe Medication Practices. - Publication:
- [Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, c2009
- Language(s):
- English
- Format:
- Text
- Subject(s):
- Medication Errors -- prevention & control
Neuromuscular Blocking Agents -- administration & dosage
Neuromuscular Blocking Agents -- adverse effects
Neuromuscular Depolarizing Agents -- administration & dosage
Neuromuscular Depolarizing Agents -- adverse effects
Risk Management -- methods
United States - Genre(s):
- Technical Report
- Abstract:
- Neuromuscular blocking agents (NMBAs) are commonly used to paralyze skeletal muscles during surgery conducted under general anesthesia and for patients requiring intubation for airway management. These medications are used in emergency departments, intensive care units, interventional radiology areas, and even medical and surgical units. NMBAs render patients unable to move or breathe and are considered high-alert drugs because misuse can lead to catastrophic injuries or death, especially when administered to patients who are not properly ventilated. Between June 2004 and March 2009, Pennsylvania healthcare facilities submitted 154 event reports that mentioned medication errors involving the use of NMBAs. Analysis reveals that the most common medication error event types associated with this class of medications were wrong-drug errors (37%) followed by wrong-dose/overdosage errors (16.2%). Further analysis showed that 47.4% of the intended medications were not NMBAs, including cases in which the patient was harmed. Strategies to address these problems include limiting access to NMBAs, segregating NMBAs from other medications, sequestering and affixing warning labels to vials of NMBAs stocked in the pharmacy, and requiring independent double checks before dispensing and administering NMBAs.
- Copyright:
- Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY-NC-DC license. (More information)
- NLM Unique ID:
- 101561932 (See catalog record)
- Permanent Link:
- http://resource.nlm.nih.gov/101561932